274 related articles for article (PubMed ID: 28977470)
1. The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.
Rengasamy M; Zhang F; Vashisht A; Song WM; Aguilo F; Sun Y; Li S; Zhang W; Zhang B; Wohlschlegel JA; Walsh MJ
Nucleic Acids Res; 2017 Nov; 45(19):11106-11120. PubMed ID: 28977470
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity.
Qi H; Shi X; Yu M; Liu B; Liu M; Song S; Chen S; Zou J; Zhu WG; Luo J
J Biol Chem; 2018 Nov; 293(46):17769-17779. PubMed ID: 30282801
[TBL] [Abstract][Full Text] [Related]
3. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract][Full Text] [Related]
4. PHD finger protein 1 (PHF1) is a novel reader for histone H4R3 symmetric dimethylation and coordinates with PRMT5-WDR77/CRL4B complex to promote tumorigenesis.
Liu R; Gao J; Yang Y; Qiu R; Zheng Y; Huang W; Zeng Y; Hou Y; Wang S; Leng S; Feng D; Yu W; Sun G; Shi H; Teng X; Wang Y
Nucleic Acids Res; 2018 Jul; 46(13):6608-6626. PubMed ID: 29846670
[TBL] [Abstract][Full Text] [Related]
5. Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.
Sheng X; Wang Z
BMC Cancer; 2016 Aug; 16():567. PubMed ID: 27480244
[TBL] [Abstract][Full Text] [Related]
6. A PRMT5-ZNF326 axis mediates innate immune activation upon replication stress.
Hoang PM; Torre D; Jaynes P; Ho J; Mohammed K; Alvstad E; Lam WY; Khanchandani V; Lee JM; Toh CMC; Lee RX; Anbuselvan A; Lee S; Sebra RP; Martin J Walsh ; Marazzi I; Kappei D; Guccione E; Jeyasekharan AD
Sci Adv; 2024 Jun; 10(23):eadm9589. PubMed ID: 38838142
[TBL] [Abstract][Full Text] [Related]
7. PRMT5 determines the sensitivity to chemotherapeutics by governing stemness in breast cancer.
Wang Z; Kong J; Wu Y; Zhang J; Wang T; Li N; Fan J; Wang H; Zhang J; Ling R
Breast Cancer Res Treat; 2018 Apr; 168(2):531-542. PubMed ID: 29185119
[TBL] [Abstract][Full Text] [Related]
8. GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.
Sheng X; Bowen N; Wang Z
Mol Cancer; 2016 Mar; 15():25. PubMed ID: 26988096
[TBL] [Abstract][Full Text] [Related]
9. PRMT1 loss sensitizes cells to PRMT5 inhibition.
Gao G; Zhang L; Villarreal OD; He W; Su D; Bedford E; Moh P; Shen J; Shi X; Bedford MT; Xu H
Nucleic Acids Res; 2019 Jun; 47(10):5038-5048. PubMed ID: 30916320
[TBL] [Abstract][Full Text] [Related]
10. ZNF326 promotes a malignant phenotype of breast cancer by interacting with DBC1.
Yu X; Wang M; Han Q; Zhang X; Mao X; Wang X; Li X; Ma W; Jin F
Mol Carcinog; 2018 Dec; 57(12):1803-1815. PubMed ID: 30175866
[TBL] [Abstract][Full Text] [Related]
11. RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells.
Bondy-Chorney E; Baldwin RM; Didillon A; Chabot B; Jasmin BJ; Côté J
Int J Biochem Cell Biol; 2017 Oct; 91(Pt B):124-135. PubMed ID: 28733251
[TBL] [Abstract][Full Text] [Related]
12. The Structure and Function of the PRMT5:MEP50 Complex.
Antonysamy S
Subcell Biochem; 2017; 83():185-194. PubMed ID: 28271477
[TBL] [Abstract][Full Text] [Related]
13. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis.
Hu D; Gur M; Zhou Z; Gamper A; Hung MC; Fujita N; Lan L; Bahar I; Wan Y
Nat Commun; 2015 Sep; 6():8419. PubMed ID: 26420673
[TBL] [Abstract][Full Text] [Related]
14. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
[TBL] [Abstract][Full Text] [Related]
15. Curcumin ameliorates PRMT5-MEP50 arginine methyltransferase expression by decreasing the Sp1 and NF-YA transcription factors in the A549 and MCF-7 cells.
Chatterjee B; Ghosh K; Suresh L; Kanade SR
Mol Cell Biochem; 2019 May; 455(1-2):73-90. PubMed ID: 30392062
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of PRMT5 by NF-Y is required for cell growth and negatively regulated by the PKC/c-Fos signaling in prostate cancer cells.
Zhang HT; Zhang D; Zha ZG; Hu CD
Biochim Biophys Acta; 2014 Nov; 1839(11):1330-40. PubMed ID: 25281873
[TBL] [Abstract][Full Text] [Related]
17. Protein Arginine Methyltransferases 5 (PRMT5) affect Multiple Stages of Autophagy and Modulate Autophagy-related Genes in Controlling Breast Cancer Tumorigenesis.
Kong J; Wang Z; Zhang Y; Wang T; Ling R
Curr Cancer Drug Targets; 2023; 23(3):242-250. PubMed ID: 36154574
[TBL] [Abstract][Full Text] [Related]
18. Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancer.
Liu X; Zhang J; Liu L; Jiang Y; Ji J; Yan R; Zhu Z; Yu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2835-2844. PubMed ID: 29802960
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
20. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Kryukov GV; Wilson FH; Ruth JR; Paulk J; Tsherniak A; Marlow SE; Vazquez F; Weir BA; Fitzgerald ME; Tanaka M; Bielski CM; Scott JM; Dennis C; Cowley GS; Boehm JS; Root DE; Golub TR; Clish CB; Bradner JE; Hahn WC; Garraway LA
Science; 2016 Mar; 351(6278):1214-8. PubMed ID: 26912360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
